Greg Mattingly, MD, founding partner of St. Charles Psychiatric Associates in St. Louis, Missouri and Associate Clinical Professor of Psychiatry, Washington University.

Interview courtesy:   Supernus Pharmaceuticals
Website for more information:   Qelbree.com

Attention-Deficit/Hyperactivity Disorder (ADHD) is one of the most common psychiatric diagnoses in adults that affects ~1 in 16 adults and 1 in 10 children in the U.S. The condition is defined as a persistent pattern of inattention and/or hyperactivity-impulsivity that can interfere with daily life.

ADHD symptoms can include inattention (like struggling to pay attention or stay organized), hyperactivity (like being restless or talking excessively) and impulsivity (like interrupting or acting without thinking). However, ADHD symptoms aren’t always universal, especially when it comes to men and women. These symptoms can have a serious impact on those living with it and can lead to people having a hard time performing daily activities or fulfilling work responsibilities because of symptoms.

Despite ADHD being a 24/7 chronic disorder, there are options for those living with the condition to help manage symptoms, which can include a combination of behavioral management techniques as well as medication. When it comes to treatment options, there is no one-size-fits-all, and sometimes it takes trying several treatment options to figure out which works. For people with ADHD, the first step is in recognizing symptoms and having open and honest conversations with a trusted healthcare provider.

To shed light on ADHD during the awareness month, Dr. Mattingly is available for interviews to discuss how ADHD can present, various treatment options, and relevant data for doctor-patient conversations. He can also speak to:

What ADHD is and how it is known to affect the brain

How men and women may experience ADHD differently, plus symptoms that are often overlooked

Ways for managing symptoms, whether for the individual or their family and loved ones

The evolving ADHD treatment landscape and updated information on how one non-stimulant treatment option interacts with the body

The post ADHD Awareness Month in October Living with the Condition & What to Know About Evolving Treatments, NOT ONLY FOR YOUNG PEOPLE! appeared first on Good News!.

BIO:
Dr. Karsh earned his MD from The Chicago Medical School. He completed his General Surgical training at The University of Colorado Health Sciences Center and his Urology Residency at the Brigham and Women’s Hospital/Harvard Medical School.
Dr. Karsh was a co-founder of The Urology Center of Colorado which was recently acquired by Advent Health Urology Denver where he serves as an attending Urologist and Director of Research. He is a certified principal investigator with an experience of more than 275 clinical trials. Dr. Karsh has authored a number of peer-reviewed publications and serves on the editorial boards for “Bladder Cancer.” He is an active member of the AUA, , ASCO, BCAN, SUO,SWOG and the Denver Academy of Surgeons. Dr. Karsh served on the board of SUO from 2010-2020 and served on the bladder cancer subcommittee during that time.

Ferring Pharmaceuticals, Inc.

Website for more information:                           ADSTILADRIN

#cancer #bladdercancer #drkarsh #mike

The post BLADDER CANCER IS THE SIXTH MOST COMMON CANCER IN THIS COUNTRY? appeared first on Good News!.

Despite many people believing the HIV crisis is “solved,” HIV remains a critical public health issue with more than 31,000[1] new diagnoses in the US each year.
Thankfully, as science and research have advanced, there are many tools available to help prevent HIV, including PrEP (pre-exposure prophylaxis) which is medicine that prevents people from getting HIV. PrEP, when taken as indicated, is highly effective, and yet many who might benefit do not receive a prescription.

http://apretude.com/

According to preliminary data released by the CDC[2], in 2022, only about 36% of the 1.2 million people who could benefit from PrEP were prescribed it.

The CDC[3] also estimates that only 10% for women who could benefit from PrEP receive a prescription for it.

October 21 marks the start of PrEP Aware Week which shines a light on the importance of HIV prevention and the communities that are disproportionately impacted by HIV. The dedicated week is a time to educate everyone on the incidence rates of HIV, who could benefit from PrEP, and where to learn more about the different options available, including a daily pill or a long-acting injectable.
On Wednesday, October 23, Dr. Kimberly Smith, Head of Research and Development at ViiV Healthcare, will discuss ViiV’s comprehensive and innovative approach to HIV prevention and treatment and the role of prevention in ending the HIV epidemic once and for all.

Interview courtesy: ViiV Healthcare

The post THE ROLE OF PREVENTION IN ENDING THE HIV EPIDEMIC FOR ALL appeared first on Good News!.